• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项评估国产单向支气管内瓣膜可操作性和安全性的临床前动物研究。

A preclinical animal study to evaluate the operability and safety of domestic one-way endobronchial valves.

作者信息

Jiao Yang, Tian Sen, Liu Jian, Shen Xiaping, Wang Qin, Li Xiang, Zhang Wei, Dong Yuchao, Li Yonghua, Bai Chong, Huang Haidong

机构信息

Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China.

Department of Respiratory and Critical Care Medicine, No. 906 Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Ningbo, China.

出版信息

Front Med (Lausanne). 2024 May 1;11:1293940. doi: 10.3389/fmed.2024.1293940. eCollection 2024.

DOI:10.3389/fmed.2024.1293940
PMID:38751979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11094200/
Abstract

PURPOSE

To evaluate the operability and safety of bronchoscopic domestic one-way endobronchial valves (EBV) on animals.

METHODS

Nine pigs were randomly assigned (2:1) to receive domestic one-way EBV (the experimental group,  = 6) and Zephyr EBV (the control group,  = 3). Routine blood tests, arterial blood gases, and CT scans of the lungs were performed 1 day pre-procedure in addition to 1 week and 1 month post-procedure to assess changes in blood markers and lung volumes. At 1 month post-procedure, the animals were sacrificed, followed by removal of all valves via bronchoscopy. Pathological examinations of critical organs were subsequently performed.

RESULTS

A total of 15 valves were placed in the experimental group and 6 valves were placed in the control group, without serious complications. Routine blood tests and arterial blood gas examinations at 1 day pre-procedure, 1 week post-procedure, and 1 month post-procedure did not differ significantly in both groups. No EBV displacement was noted under bronchoscopy, and the valve was smoothly removable by bronchoscope at 1 month post-procedure. At 1 week post-procedure, varying degrees of target lung lobe volume reduction were observed on lung CT in both groups. Lung volume reduction was achieved at 1 month post-procedure in both groups, without significant statistical difference. Although 3 cases in the experimental group and 1 case in the control group developed varying degrees of pneumonia, the inflammatory response did not increase over time during the experimental period. Pathological examination revealed no significant abnormal changes in the critical organs for both groups.

CONCLUSION

Our results demonstrate that domestic EBV is safe and reliable for endobronchial application in general-grade laboratory white pigs. The safety of domestic EBV is similar to that of Zephyr EBV, with good ease of use and operability. This kind of domestic EBV can meet the safety evaluation requirements for animal testing.

摘要

目的

评估国产支气管镜单向支气管内瓣膜(EBV)在动物身上的可操作性和安全性。

方法

将9头猪随机分为两组(2:1),分别接受国产单向EBV(实验组,n = 6)和Zephyr EBV(对照组,n = 3)。在手术前1天、术后1周和1个月进行常规血液检查、动脉血气分析和肺部CT扫描,以评估血液指标和肺容积的变化。术后1个月,处死动物,然后通过支气管镜取出所有瓣膜。随后对关键器官进行病理检查。

结果

实验组共置入15个瓣膜,对照组置入6个瓣膜,均未出现严重并发症。两组在手术前1天、术后1周和术后1个月的常规血液检查和动脉血气分析结果无显著差异。支气管镜检查未发现EBV移位,术后1个月瓣膜可通过支气管镜顺利取出。术后1周,两组肺部CT均观察到不同程度的目标肺叶容积缩小。两组术后1个月均实现了肺容积缩小,差异无统计学意义。虽然实验组有3例、对照组有1例出现不同程度的肺炎,但在实验期间炎症反应未随时间增加。病理检查显示两组关键器官均无明显异常变化。

结论

我们的结果表明,国产EBV在内科级实验用白猪支气管内应用是安全可靠的。国产EBV的安全性与Zephyr EBV相似,具有良好的易用性和可操作性。这种国产EBV能够满足动物试验的安全性评估要求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/70e3c8e55317/fmed-11-1293940-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/e4f2bbd0c88f/fmed-11-1293940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/d76e2226f6dd/fmed-11-1293940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/c24586b412a9/fmed-11-1293940-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/39a37ef3b6e2/fmed-11-1293940-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/70e3c8e55317/fmed-11-1293940-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/e4f2bbd0c88f/fmed-11-1293940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/d76e2226f6dd/fmed-11-1293940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/c24586b412a9/fmed-11-1293940-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/39a37ef3b6e2/fmed-11-1293940-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08db/11094200/70e3c8e55317/fmed-11-1293940-g005.jpg

相似文献

1
A preclinical animal study to evaluate the operability and safety of domestic one-way endobronchial valves.一项评估国产单向支气管内瓣膜可操作性和安全性的临床前动物研究。
Front Med (Lausanne). 2024 May 1;11:1293940. doi: 10.3389/fmed.2024.1293940. eCollection 2024.
2
Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial.支气管内瓣膜(Zephyr)治疗均质性肺气肿:IMPACT 随机临床试验一年结果。
Respiration. 2021;100(12):1174-1185. doi: 10.1159/000517034. Epub 2021 Jul 23.
3
Endobronchial valves: 1st Multicenter retrospective study on the 2-step approach.支气管内瓣膜:2 步治疗法的首个多中心回顾性研究。
Respir Med Res. 2023 Jun;83:100957. doi: 10.1016/j.resmer.2022.100957. Epub 2022 Oct 1.
4
When Treatment of Pulmonary Emphysema with Endobronchial Valves Did Not Work: Evaluation of Quantitative CT Analysis and Pulmonary Function Tests Before and After Valve Explantation.经支气管活瓣置入术治疗肺气肿无效时:活瓣取出前后定量 CT 分析和肺功能测试评估。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 11;17:2553-2566. doi: 10.2147/COPD.S367667. eCollection 2022.
5
First in Human Experience of the Performance of the New 5.5-LP Size Zephyr Endobronchial Valve.新型 5.5-LP 尺寸 Zephyr 支气管内瓣膜的人体首秀。
Respiration. 2020;99(1):50-55. doi: 10.1159/000504182. Epub 2019 Nov 26.
6
First in vivo Experiment with PulmValve Endobronchial Valve: Feasibility, Efficiency, and Safety.首例经支气管活瓣肺减容术的体内实验:可行性、有效性和安全性。
Respiration. 2024;103(6):344-352. doi: 10.1159/000538269. Epub 2024 Mar 26.
7
Lung volume reduction for emphysema using one-way endobronchial valves: An Australian cohort.使用单向支气管内瓣膜进行肺气肿肺减容术:澳大利亚队列研究。
Medicine (Baltimore). 2023 Aug 4;102(31):e34434. doi: 10.1097/MD.0000000000034434.
8
From plugging air leaks to reducing lung volume: a review of the many uses of endobronchial valves.从封堵漏气到减少肺容积:支气管内瓣膜的多种用途综述
Expert Rev Med Devices. 2023 Jul-Dec;20(9):721-727. doi: 10.1080/17434440.2023.2233435. Epub 2023 Jul 7.
9
Device profile of the Zephyr endobronchial valve in heterogenous emphysema: overview of its safety and efficacy.Zephyr 支气管内阀在肺气肿中的器械特征:安全性和疗效概述。
Expert Rev Med Devices. 2021 Sep;18(9):823-832. doi: 10.1080/17434440.2021.1957831. Epub 2021 Aug 11.
10
Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction.用于内镜下肺减容的支气管内瓣膜:内镜下肺减容专家小组的最佳实践建议
Respiration. 2017;93(2):138-150. doi: 10.1159/000453588. Epub 2016 Dec 20.

本文引用的文献

1
Surgical and bronchoscopic pulmonary function-improving procedures in lung emphysema.肺肺气肿的手术和支气管镜肺功能改善术。
Eur Respir Rev. 2023 Dec 20;32(170). doi: 10.1183/16000617.0004-2023. Print 2023 Dec 31.
2
Nonpharmacological interventions in COPD.COPD 的非药物干预措施。
Eur Respir Rev. 2023 Mar 22;32(167). doi: 10.1183/16000617.0028-2023. Print 2023 Mar 31.
3
Improved exercise capacity results in a survival benefit after endobronchial valve treatment.支气管内瓣膜治疗后运动能力的改善带来生存获益。
Respir Med. 2023 Apr-May;210:107175. doi: 10.1016/j.rmed.2023.107175. Epub 2023 Feb 28.
4
The role of confocal laser endomicroscopy in pulmonary medicine.共聚焦激光内镜在肺部医学中的应用。
Eur Respir Rev. 2023 Jan 25;32(167). doi: 10.1183/16000617.0185-2022. Print 2023 Mar 31.
5
Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?表型 COPD 研究:缺氧诱导因子-2 作为血管表型和气道表型之间的分子“开关”?
Eur Respir Rev. 2023 Jan 11;32(167). doi: 10.1183/16000617.0173-2022. Print 2023 Mar 31.
6
Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema.支气管镜下肺减容瓣膜治疗肺气肿后的长期随访
ERJ Open Res. 2022 Nov 21;8(4). doi: 10.1183/23120541.00235-2022. eCollection 2022 Oct.
7
When Treatment of Pulmonary Emphysema with Endobronchial Valves Did Not Work: Evaluation of Quantitative CT Analysis and Pulmonary Function Tests Before and After Valve Explantation.经支气管活瓣置入术治疗肺气肿无效时:活瓣取出前后定量 CT 分析和肺功能测试评估。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 11;17:2553-2566. doi: 10.2147/COPD.S367667. eCollection 2022.
8
Prescribing and adjusting exercise training in chronic respiratory diseases - Expert-based practical recommendations.慢性呼吸系统疾病运动训练的开具和调整 - 基于专家的实用建议。
Pulmonology. 2023 Jul-Aug;29(4):306-314. doi: 10.1016/j.pulmoe.2022.09.004. Epub 2022 Oct 20.
9
Clinical outcomes and quantitative CT analysis after bronchoscopic lung volume reduction using valves for advanced emphysema.晚期肺气肿患者使用瓣膜进行支气管镜肺减容术后的临床结局及定量CT分析
J Thorac Dis. 2022 Jun;14(6):1922-1932. doi: 10.21037/jtd-21-1734.
10
Clinical Impact of Compensatory Hyperinflation of the Nontreated Adjacent Lobe After Bronchoscopic Lung Volume Reduction with Valves.支气管镜肺减容术后未处理相邻肺叶的补偿性过度充气的临床影响。
Int J Chron Obstruct Pulmon Dis. 2022 Jul 1;17:1523-1536. doi: 10.2147/COPD.S364448. eCollection 2022.